Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency.

Schiff M, Mohsen AW, Karunanidhi A, McCracken E, Yeasted R, Vockley J.

Mol Genet Metab. 2013 May;109(1):21-7. doi: 10.1016/j.ymgme.2013.02.002. Epub 2013 Feb 13.

2.

Initial In Vivo Quantification of Tc-99m Sestamibi Uptake as a Function of Tissue Type in Healthy Breasts Using Dedicated Breast SPECT-CT.

Mann SD, Perez KL, McCracken EK, Shah JP, Wong TZ, Tornai MP.

J Oncol. 2012;2012:146943. doi: 10.1155/2012/146943. Epub 2012 Aug 16.

3.

Genotype-phenotype analysis of 4q deletion syndrome: proposal of a critical region.

Strehle EM, Yu L, Rosenfeld JA, Donkervoort S, Zhou Y, Chen TJ, Martinez JE, Fan YS, Barbouth D, Zhu H, Vaglio A, Smith R, Stevens CA, Curry CJ, Ladda RL, Fan ZJ, Fox JE, Martin JA, Abdel-Hamid HZ, McCracken EA, McGillivray BC, Masser-Frye D, Huang T.

Am J Med Genet A. 2012 Sep;158A(9):2139-51. doi: 10.1002/ajmg.a.35502. Epub 2012 Jul 27.

PMID:
22847869
4.

A radar-enabled collaborative sensor network integrating COTS technology for surveillance and tracking.

Kozma R, Wang L, Iftekharuddin K, McCracken E, Khan M, Islam K, Bhurtel SR, Demirer RM.

Sensors (Basel). 2012;12(2):1336-51. doi: 10.3390/s120201336. Epub 2012 Jan 31.

5.

Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes.

Rosenfeld JA, Traylor RN, Schaefer GB, McPherson EW, Ballif BC, Klopocki E, Mundlos S, Shaffer LG, Aylsworth AS; 1q21.1 Study Group.

Eur J Hum Genet. 2012 Jul;20(7):754-61. doi: 10.1038/ejhg.2012.6. Epub 2012 Feb 8.

6.

A copy number variation morbidity map of developmental delay.

Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J, Shashi V, Johnson K, Rehder C, Ballif BC, Shaffer LG, Eichler EE.

Nat Genet. 2011 Aug 14;43(9):838-46. doi: 10.1038/ng.909. Erratum in: Nat Genet. 2014 Sep;46(9):1040.

7.

Testicular choriocarcinoma: an unusual case of paraneoplastic thyrotoxicosis.

McCracken EJ, Johnston PC, Lindsay JR, Mulholland C, McAleer JJ, Black RN.

QJM. 2012 Jul;105(7):675-7. doi: 10.1093/qjmed/hcr084. Epub 2011 Jun 6. No abstract available.

8.

Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.

Wang X, Di Pasqua AJ, Govind S, McCracken E, Hong C, Mi L, Mao Y, Wu JY, Tomita Y, Woodrick JC, Fine RL, Chung FL.

J Med Chem. 2011 Feb 10;54(3):809-16. doi: 10.1021/jm101199t. Epub 2011 Jan 11.

9.

Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates.

Di Pasqua AJ, Hong C, Wu MY, McCracken E, Wang X, Mi L, Chung FL.

Chem Res Toxicol. 2010 Aug 16;23(8):1307-9. doi: 10.1021/tx100187f.

10.

TRIAD II: do living wills have an impact on pre-hospital lifesaving care?

Mirarchi FL, Kalantzis S, Hunter D, McCracken E, Kisiel T.

J Emerg Med. 2009 Feb;36(2):105-15. doi: 10.1016/j.jemermed.2008.10.003. Epub 2009 Jan 20.

PMID:
19157750
11.

PF4/heparin complexes are T cell-dependent antigens.

Suvarna S, Rauova L, McCracken EK, Goss CM, Sachais BS, McKenzie SE, Reilly MP, Gunn MD, Cines DB, Poncz M, Arepally G.

Blood. 2005 Aug 1;106(3):929-31. Epub 2005 Apr 21.

12.

Intracerebral injection of AMPA causes axonal damage in vivo.

Fowler JH, McCracken E, Dewar D, McCulloch J.

Brain Res. 2003 Nov 21;991(1-2):104-12.

PMID:
14575882
13.

Sipatrigine and oligodendrocyte and axonal pathology following transient focal cerebral ischaemia in the rat.

McCracken E, Dewar D, McCulloch J.

Neuroreport. 2003 Mar 3;14(3):517-20.

PMID:
12634515
14.

Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502.

McCracken E, Fowler JH, Dewar D, Morrison S, McCulloch J.

J Cereb Blood Flow Metab. 2002 Sep;22(9):1090-7.

15.

White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat.

McCracken E, Dewar D, Hunter AJ.

Brain Res. 2001 Feb 23;892(2):329-35.

PMID:
11172780
16.

The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes.

McCracken E, Valeriani V, Simpson C, Jover T, McCulloch J, Dewar D.

J Cereb Blood Flow Metab. 2000 Nov;20(11):1529-36.

17.

Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischemia in mice.

Horsburgh K, McCulloch J, Nilsen M, McCracken E, Large C, Roses AD, Nicoll JA.

J Cereb Blood Flow Metab. 2000 Mar;20(3):458-62.

18.

Neuregulin signaling in brain injury and in animal models of ischemia.

Marchionni MA, Soriano MA, Murdoch I, McCracken E, Dewar D, McCulloch J.

Ann N Y Acad Sci. 1999;890:355. No abstract available.

PMID:
10668441
19.

Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients.

McCracken E, Hunter AJ, Patel S, Graham DI, Dewar D.

J Neurotrauma. 1999 Sep;16(9):749-61.

PMID:
10521135
20.

Mechanisms of recovery of swallow after supraglottic laryngectomy.

Logemann JA, Gibbons P, Rademaker AW, Pauloski BR, Kahrilas PJ, Bacon M, Bowman J, McCracken E.

J Speech Hear Res. 1994 Oct;37(5):965-74.

PMID:
7823564
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk